LakeWalesNews.net - Hometown stories that count from people who care

AdventHealth Recruiting Participants for Phase 3 COVID-19 Investigational Vaccine Clinical Trial

 

Last updated 11/11/2020 at 9:59am

AdventHealth will be a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson's Phase 3 clinical research study, ENSEMBLE trial, to evaluate the safety and efficacy of Janssen's investigational COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S.

The Phase 3 randomized, double-blind, placebo-controlled clinical trial is designed to evaluate the safety and efficacy of a single vaccine dose of the Janssen COVID-19 vaccine candidate versus placebo, in approximately 60,000 adults 18 years old and older, including significant representation from those th...



For access to this article please sign in or register.

 

Reader Comments(0)

 
 

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2021

Rendered 07/27/2021 07:28